Lonza Group AG
OTC: LZAGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Wolfgang Wienand
- Employees
- 17,995
- Headquarters
- Basel, Switzerland
- IPO year
- 2009
- Market cap
- $42.9B
- Website
- https://www.lonza.com
Loading LZAGF…
Loading profile data…Frequently asked questions about LZAGF
What does Lonza Group AG (LZAGF) do?
Lonza Group AG, established in 1897 and based in Basel, Switzerland, is a global enterprise that furnishes critical products and services to the pharmaceutical, biotechnology, and nutrition sectors. Its operational footprint extends across Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and beyond. The company's a...
Where does LZAGF trade?
Lonza Group AG (LZAGF) trades on the Other OTC.
What sector is LZAGF in?
Lonza Group AG (LZAGF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Lonza Group AG?
Wolfgang Wienand is the chief executive officer of Lonza Group AG (LZAGF).
Where is Lonza Group AG headquartered?
Lonza Group AG is headquartered in Switzerland.
Does LZAGF pay a dividend?
Yes — Lonza Group AG (LZAGF) paid a trailing twelve-month dividend of USD 3.19 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did LZAGF go public?
Lonza Group AG (LZAGF) completed its initial public offering in 2009.